ArticleSurgical endoscopy2025
Three-dimensional printing-assisted Amplatzer II-type occluder or coil therapy for peripheral bronchopleural fistula.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interventional techniques and strategies for postoperative bronchopleural fistula treatment: a narrative review.Journal of thoracic disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo explore the feasibility and safety of using 3D-printed models to assist in the treatment of refractory peripheral bronchopleural fistulas with Amplatzer II-type occluders or coils.
methodsThis was a retrospective analysis of 13 patients-10 males (76.9%) and 3 females (23.1%)-with an average age of 65.62 ± 12.30 years (34-83 years), who were treated at our center between April 2023 and August 2024 for peripheral bronchopleural fistulas. Primary diseases included lung cancer, esophageal cancer, severe pneumonia, and pulmonary hydatid disease. The fistulas were located in the right lung in 6 patients (46.2%) and in the left lung in 7 patients (53.8%), with a total of 19 fistulas in 13 patients. All the patients were diagnosed, with their fistula locations identified using 3D-printed models combined with tracheoscopic thoracic drainage tube injection of methylene blue, and were treated with Amplatzer II-type occluders or coils.
resultsAll 19 fistulas were successfully occluded in a single attempt, with a technical success rate of 100%; coils were used in 4 patients (21.1%) and Amplatzer II-type occluders in 15 patients (78.9%). In 12 patients (12/13, 92.3%), the empyema cavities closed or were successfully drained without fluid, allowing for the removal of chest drainage tubes. In one patient (1/13, 7.7%), despite the occluder being well placed, there was no significant improvement in subcutaneous or mediastinal air accumulation, resulting in a clinical success rate of 92.3%. One month post-operation, significant differences in body temperature, white blood cell count, and performance status (PS) score were noted compared with preoperation values.
conclusion3D printing aids in the diagnosis and localization of peripheral bronchopleural fistulas. The use of vascular plugs or coils for occlusion treatment is safe and effective and is worthy of clinical promotion.
Indexed as
Identifiers
41136650What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.